---
title: "ANIP: Q2 2026 delivered 26% revenue growth, led by Rare Disease and Cortrophin Gel's 43% surge"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295230809.md"
description: "Q2 2026 saw 26% revenue growth and 32% higher adjusted EBITDA, driven by Rare Disease and generics. Cortrophin Gel led with 43% growth, and guidance for 2026 was reaffirmed, projecting strong top- and bottom-line expansion.Original document: ANI Pharmaceuticals, Inc. [ANIP] Slides Release — Aug. 7 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-07T11:58:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295230809.md)
  - [en](https://longbridge.com/en/news/295230809.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295230809.md)
generator: "portal-rs"
---

# ANIP: Q2 2026 delivered 26% revenue growth, led by Rare Disease and Cortrophin Gel's 43% surge

Q2 2026 saw 26% revenue growth and 32% higher adjusted EBITDA, driven by Rare Disease and generics. Cortrophin Gel led with 43% growth, and guidance for 2026 was reaffirmed, projecting strong top- and bottom-line expansion.

Original document: ANI Pharmaceuticals, Inc. \[ANIP\] Slides Release — Aug. 7 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ANIP.US](https://longbridge.com/en/quote/ANIP.US.md)

## Related News & Research

- [ANI Pharma SVP, CFO Stephen P. Carey sells 2,850 shares for $207,480](https://longbridge.com/en/news/297704077.md)
- [Hikers 'relied too much' on AI and had to be rescued. A ranger says it wasn't the first AI-related mishap he's seen.](https://longbridge.com/en/news/298103029.md)
- [With Cybersecurity for Cloud and Artificial Intelligence, CrowdStrike Stock Is Positioned for Sustained Growth](https://longbridge.com/en/news/297686539.md)
- [Iomart publishes 2026 annual report](https://longbridge.com/en/news/297739507.md)
- [Igua Sergipe board signs off Q2 2026 financial results](https://longbridge.com/en/news/297932404.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**